Gene therapy strategies to facilitate organ transplantation.
Organ transplantation is now the definitive therapy for many forms of end-organ disease, but chronic allograft rejection, the side effects of chronic immunosuppressive therapy and the severe donor organ shortage continue to limit its success. Gene therapy has the potential to prevent graft rejection by manipulating the immune response in the microenvironment of the graft or by facilitating the induction of tolerance. Genetic manipulation of stem cells to create transgenic and/or knockout animals that could serve as organ or cell donors could be combined with gene therapy approaches to overcome the problem of limited allogeneic donor organ supply.
Deng
S
S
Multiorgan Transplant Service, London Health Sciences Center, University of Western Ontario, London, Canada N6G 5A5.
Brayman
K L
KL
D000818:Animals; D015316:Genetic Therapy; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007108:Immune Tolerance; D016377:Organ Transplantation; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous